IP Verse

Wichmann patent opposition analysis

The comprehensive analysis of Wichmann opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Wichmann

Stay updated with the latest patent oppositions filed by Wichmann

Patent NumberTitleApplicantOpposition DateOpposition Company
EP3858859
Method Of Treating Cancer Using Immune Checkpoint Inhibitor; Antibody That Binds To Programmed Death-1 Receptor (Pd-1) Or Programmed Death Ligand 1 (Pd-L1)BRISTOL MYERS SQUIBBMar 12, 2026WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBB
EP3359572
Method For Treating Multiple SclerosisF HOFFMANN LA ROCHEAug 26, 2025POLPHARMA BIOLOGICS
EP3509637
Methods Of Using A Bispecific Antibody That Recognizes Coagulation Factor Ix And/Or Activated Coagulation Factor Ix And Coagulation Factor X And/Or Activated Coagulation Factor XF HOFFMANN LA ROCHEAug 25, 2025WUESTHOFF & WUESTHOFF
EP4152004
Assay For Jc Virus AntibodiesBIOGEN MAAug 19, 2025POLPHARMA BIOLOGICS
EP3689365
Use Of Long-Acting Glp-1 PeptidesNOVO NORDISKAug 6, 2025WUESTHOFF & WUESTHOFF
EP3638243
Methods For Treating Myeloproliferative Neoplasm-Associated Myelofibrosis And AnemiaCELGENEMay 5, 2025WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBB
EP3490582
Methods And Compositions For Treating MyelofibrosisACCELERON PHARMAMar 10, 2025WUESTHOFF & WUESTHOFF
EP3529360
Methods For Preventing Cardiovascular Events Through Proprotein Convertase Subtilisin Kexin 9 (Pcsk9) Protein ReductionTHE MEDICINESJan 15, 2025POLPHARMA
EP3227447
Guide Rna With Chemical ModificationsAGILENTJan 14, 2025WUESTHOFF & WUESTHOFF
EP3226887
Methods For Treating Myelodysplastic Syndromes And Sideroblastic AnemiasACCELERON PHARMADec 20, 2024WUESTHOFF & WUESTHOFF

Top clients of Wichmann

Top companies who are the clients of Wichmann

CompanyTotal
WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBB26
POLPHARMA BIOLOGICS9
WUESTHOFF & WUESTHOFF8
POLPHARMA4
PHARMACEUTICAL WORKS POLPHARMA3
COOKE3
NOVOZYMES2
RIGONTEC2
SANDOZ2
MERCK SHARP & DOHME1